C9orf72 and frontotemporal dementia: Finally, a longitudinal study [9] reported that King’s ALS disease stages estimated from the ALSFRS-R correlated with CST diffusion measures in C9orf72 carriers with heterogeneous clinical presentations (asymptomatic subjects, and ALS, ALS-FTD, and bvFTD patients).